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ABSTRACT
We have investigated the DNA-binding nature as
well as the function of a putative Alba (Acetylation
lowers binding affinity) family protein (PfAlba3)
from Plasmodium falciparum. PfAlba3 possesses
DNA-binding property like Alba family proteins.
PfAlba3 binds to DNA sequence non-specifically
at the minor groove and acetylation lowers its
DNA-binding affinity. The protein is ubiquitously
expressed in all the erythrocytic stages of P. falcip-
arum and it exists predominantly in the acetylated
form. PfAlba3 inhibits transcription in vitro by
binding to DNA. Plasmodium falciparum Sir2
(PfSir2A), a nuclear localized deacetylase interacts
with PfAlba3 and deacetylates the lysine residue of
N-terminal peptide of PfAlba3 specific for DNA
binding. PfAlba3 is localized with PfSir2A in the per-
iphery of the nucleus. Fluorescence in situ hybrid-
ization studies revealed the presence of PfAlba3 in
the telomeric and subtelomeric regions. ChIP and
ChIP ReChIP analyses further confirmed that
PfAlba3 binds to the telomeric and subtelomeric
regions as well as to var gene promoter.
INTRODUCTION
Human malaria parasite Plasmodium falciparum (P. falcip-
arum) causes one of the most life-threatening diseases,
accounting for nearly 1.5–2.7 million deaths annually (1).
Unfortunately, the management of malaria is becoming a
difﬁcult task due to the development of resistance against
currently used drugs (2,3). Identiﬁcation and characteriza-
tion of novel protein from P. falciparum are accepted
as a fundamental approach to understand parasite
biology. Genome sequencing and transcriptome analysis
of P. falciparum provides an excellent opportunity to
identify important protein from the parasite (4).
Comprehensive genome analysis of P. falciparum reveals
that it encodes each of core histone together with his-
tone variants H2A.Z, H3.3, centromere-speciﬁc H3
(CenH3), H4 and H2Bv, expressed differentially during
different intra-erythrocytic stages (5,6). Besides histones,
Plasmodium genome constitutes other expanded family of
DNA-binding proteins involved in regulation of gene ex-
pression (7–13). Plasmodium falciparum genome encodes
novel DNA–RNA-binding proteins show homology with
Alba super-family conserved domain (Archeal chromatin
protein family Alba), well characterized in hyper-
thermophilic Sulfolobus spp. (14–19). Genome search
reveals the presence of three homologs of DNA–
RNA-binding protein belonging to Alba family termed
as Alba 1(Pf08_0074), Alba 2 (MAL13P1.233) and Alba
3 (Pf10_0063), which may play an important role in
parasite biology (http://www.genedb.org). Alba super
family proteins are originated as RNA-binding proteins
that unify the Alba proteins with RNase P subunit (20).
The Alba protein (previously named as Sso10b) identiﬁed
as a major architectural DNA-binding protein (15),
which organizes and regulates the genome of both
euryarchea (having histone) as well as crenarchea
(having no histone) (21,22). Alba is controlled by acetyl-
ation and deacetylation, where acetylation at speciﬁc
N-terminal lysine residue lowers its binding afﬁnity
toward double-strand (ds) DNA (14,19). In Sulfolobus
solfatataricus, Alba was found to be reversibly acetylated
at lys 16 by a homolog of Pat (protein acetyltransferase)
and deacetylated by Sir2 protein (a sirtuin family
deacetylase) (14,17,23). Alba proteins also contain RGG
repeats at C-terminal and the afﬁnity of these repeats for
RNA is modulated through the methylation of arginine in
many RGG-box proteins (20,24). Apart from this
phosphoproteome analysis also revealed the presence of
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dsDNA cooperatively without signiﬁcant compaction
(26) in a sequence-independent manner and distributed
uniformly on the chromosomes (14,18). Crystal structure
of Alba protein reveals homodimer (dimeric) nature
(common a/b fold), sharing the N-terminal domain of
DNase I and the C-terminal domain of translation initi-
ation factor (14,27). In S. solfatataricus, two copies of
Alba protein (Alba 1 and Alba 2) are reported, which
exist exclusively as heterodimer (28). Plasmodium falcip-
arum genome also encodes a homolog of yeast Sir2 well
characterized in the apicomplexians (13,29,30). In P. fal-
ciparum, Sir2 (PfSir2A) is nuclear localized (telomeric and
subtelomeric) and involved in silencing of different var
gene subsets (11,31,32). Plasmodium falciparum var
gene family encodes the variant surface antigen PfEMP1
(P. falciparum erythrocyte membrane protein 1) (33,34)
and associated with various endothelial receptors
(i.e. ICAM-1, CD36 and CSA) (35). Studies on var gene
expression revealed that histone modiﬁcation pattern as
well as interactions of different nuclear proteins (unique
to either subtelomeric or internal chromosomal var gene
promoters) is associated with var gene silencing (36–38).
PfHP1 (P. falciparum heterochromatin 1) and histone
variant H2A.Z were also shown to be linked with
mutually exclusive expression of var genes (39,40).
PfSir2A plays a key role in heterochromatin-mediated
silencing and comprehensive repression and switching ex-
pression of var genes (31,41). Sir2 from P. falciparum and
Saccharomyces cerevisiae is associated with silent chroma-
tin and binds to regions of the chromosomes that are tran-
scriptionally suppressed comprising the telomeric and
subtelomeric regions (42,43). The crucial role of PfSir2A
and histone acetylation in var gene regulation was also
established by gene disruption studies (32,41). Recent
studies documented the presence of an additional plasmo-
dial histone deacetylase, termed PfSir2B, involved exclu-
sively in the expression of the ups B subtype (32). These
ﬁndings validated the involvement of two paralogs of Sir2
(termed as PfSir2A and PfSir2B) that cooperate to
regulate the expression of thevargene repertoire inP. fal-
ciparum. Furthermore, Sir2 paralogs also played an im-
portant role in the regulation of other antigenically
variant genes (such as rif gene families) as well as main-
tained telomere repeat length (32). Apart from this, a
broad range of histone acetyltransferse has also been
identiﬁed in Plasmodium genome, only a few of them
have been characterized till date (44). The wide presence
of these acetylase and deacetylase in Plasmodium suggests
the crucial role performed by them and their target
proteins. PfAlba3 may be one of the possible targets of
this global machinery for the regulation of cellular growth
and development. Information regarding PfAlba3 is cur-
rently insufﬁcient to elucidate its role in P. falciparum.
Here, we have characterized DNA-binding properties of
PfAlba3 and shown the association of this protein with
PfSir2A at telomeric and subtelomeric region of chromo-
somes. It has been conﬁrmed that PfAlba3 binds dsDNA
sequence non-speciﬁcally and acetylation of this protein
lowers its DNA-binding afﬁnity; a feature shared by
Alba family proteins. PfAlba3 is expressed throughout
all the asexual blood stages and binding of PfAlba3 to
DNA inhibits transcription. We also provide evidence
that protein exists as an acetylated form and the
N-terminal peptide of PfAlba3 could be deacetylated by
PfSir2A, speciﬁcally at lysine 22 of KKP motif. This
protein interacts with PfSir2A and occupies mainly the
periphery of the nucleus encompassing the telomeric and
subtelomeric region including var gene promoter.
MATERIALS AND METHODS
Cloning and expression
RT–PCR ampliﬁed cDNA fragment corresponding to the
PfAlba3 (Pf10_0063, 324bp) and PfSir2A (Pf13_0152,
822bp) was cloned into the pET-28a (PfAlba3) or
pET28a and pGEX-5X-3 (PfSir2A) vector to express the
recombinant protein. Identity of resultant recombinant
clone was conﬁrmed by DNA sequencing on an auto-
mated sequencer (3730 Analyzer-17121-005, Applied
Bio-system) at gene sequencing facility, University of
Delhi, South campus. The sequence was compared with
the existing sequences from the Malaria Genome
Consortium (www.plasmodb.org) using BLASTN
program. For recombinant protein expression, pET-28a-
PfAlba3 clone was transformed into the Escherichia coli
BL21 (Rosetta) strain and protein synthesis was induced
with 1mM IPTG when OD600 reached at 0.4–0.6. Culture
was further grown for 6h under same conditions. Cells
were harvested by centrifugation, resuspended in 15ml
of lysis buffer (50mM Tris–HCl, pH 8.0, 300mM NaCl,
10mM imidazole and 10% glycerol) containing 1mg/ml
lysozyme and protease inhibitor cocktail. Cells were
incubated for 30min on ice and lysed by sonication with
pulse-rest cycle (10 cycles; 10s pulse at 25W with 1min
interval after each pulse). The protein was puriﬁed by
Ni-NTA column afﬁnity chromatography. Recombinant
protein was concentrated by using Millipore ﬁltration
units. The protein was further puriﬁed by HPLC using
protein-pak
TM 125A gel-ﬁltration column (Waters,
7.8 300mm) by running in 20mM Tris–HCl buffer
(pH 8.0) containing 100mM NaCl at a ﬂow rate of
0.5ml/min. Puriﬁed protein was subjected to extensive
dialysis (10kDa cut off membrane, Pierce) against
10mM Tris–HCl, pH-8.0, 20% glycerol and 50mM
NaCl and 2mM DTT. For PfSir2A expression,
PfSir2A-pET-28a and PfSir2A-pGEX-5X-3 clones were
transformed in BL21 (DE3)/pLys E. coli and BL21
(DE3) cells, respectively. Recombinant protein synthesis
was induced by the addition of 0.1mM IPTG at
OD600=0.25. Cells were grown overnight at room tem-
perature. Recombinant His and GST fusion PfSir2A was
puriﬁed using Ni-NTA and GST column chromatography
respectively. Homogeneity of the recombinant protein was
checked by SDS–PAGE and western blotting using
anti-PfAlba3 and anti-PfSir2A antibodies. The concentra-
tion of the protein was determined as described (45).
Agarose gel-retardation assay
DNA-binding activity of PfAlba3 was analyzed by using
agarose gel-retardation assay as described previously (27).
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incubated with various concentrations of native
(non-acetylated)/acetylated PfAlba3 in binding buffer
(20mM MES, pH 6.5, 100mM potassium glutamate,
1mM MgCl2 and 0.1mg/ml bovine serum albumin) in a
total volume of 10ml. After 15min at 20 C, one-sixth
volume of loading buffer (6 loading dye 0.25%
bromophenol blue, 0.25% xylene cyanol FF, 35% ﬁcoll
type 400) was added and samples were electrophoresed
(in 0.7% agarose, 1 TBE) at 10V/cm for 90min.
After electrophoresis, gels were stained in ethidium
bromide and visualized under UV light.
Electrophoretic mobility shift assay
Sequences of oligonucleotides and their corresponding
complements used for electrophoretic mobility shift
assay (EMSA) were as follows: 30-bp-50CATGGATGA
AGAAAGATAGAGAACCAATAG 30 and 50 CTATT
GGTTCTCTATCTTTCTTCATCCATG 30. The 20-bp-
50AGAAAGATAGGGATGGGATG 30 and 50CATCCC
ATCCCTATCTTTCT 30, respectively (Sigma Aldrich).
Synthetic oligonucleotides were annealed to create ds
and 50-end-labeled with [g-
32P] ATP using T4 polynucleo-
tide kinase, according to standard protocols.
Unincorporated [g-
32P] ATP was removed by ethanol pre-
cipitation at  20 C (overnight) followed by washing with
70% ethanol. Reactions were performed in a volume of
10ml containing
32P-labeled ds oligonucleotide probes
(50nM) incubated with recombinant PfAlba3 in binding
buffer (10mM HEPES buffer, pH 7.6, 50mM NaCl,
1mM EDTA, 5mM MgCl2, 0.1mM dithiothreitol, 1mg/
ml BSA and 0.05% Triton X-100) for 30min on ice.
Complexes were separated by native gel electrophoresis
(7%) running under 10V/cm at 4 C with 0.5 TBE
(Tris/borate/EDTA; 1 TBE=45mM Tris–borate and
1mM EDTA) running buffer. Supershift assay was per-
formed by adding anti-PfAlba3 polyclonal antibody in the
reaction. For competition assay, unlabeled competitor
oligonucleotides (same oligonucleotides in 1- to 100-fold
molar excess) were added at the start of the incubation.
The gel was dried and exposed to an X-ray ﬁlm overnight
at  80 C before ﬁlm development. The intensity of free
and bound DNA was quantiﬁed by using phosphoimager
and auto-radiograph analysis (Image J software).
Dissociation constant of protein–DNA complexes was
determined using linear regression according to the
Scatchard equation as described previously (46). In
short, 50nM of ds oligos (20bp) were incubated with
increasing concentrations of PfAlba3 for 30min on ice
and the products were resolved in 7% native PAGE.
Data were analyzed using Scatchard equation r/[A]=
 (1/ Kdapp) r+n/Kdapp, where the ratio of protein bound
oligos to total oligos [{PfAlba3-oligo}/ oligoT] denoted as
r, [A] referred to PfAlba3 concentration and Kdapp is
apparent dissociation constant, while n is the number
of binding sites for protein. Speciﬁcity of PfAlba3
binding to major or minor groove of dsDNA was
studied by using groove speciﬁc dye as a competitor as
described earlier (47). In brief,
32P-labeled ds oligos
(30bp) were pre-incubated with increasing concentrations
of actinomycin D (Gibco Biosciences) and methyl green
(Sigma) for 30min at 20 C in a reaction volume of 20mli n
binding buffer. Following incubation, PfAlba3 (500nM)
was added to the reaction mixture, and allowed to an add-
itional incubation on ice for 30min. The DNA–protein
complex was analyzed on a 7% native polyacrylamide
gel in 0.5 TBE at 150V at 4 C for 2–3h.
RT–PCR and western blotting for stage-speciﬁc
expression
Stage-speciﬁc expression of PfAlba3 and PfSir2A was
checked by using RT–PCR and western blotting.
Parasites from different stages were obtained after cultur-
ing ring-synchronized P. falciparum. Synchronization of
culture was done as described earlier (48–50). To check
the stage-speciﬁc expression, equivalent amount of RNA
(1mg) from different stages was used as template to
amplify PfAlba3, PfSir2A and seryl tRNA synthetase.
Seryl tRNA synthetase expresses equally in each stage of
the P. falciparum used as a positive control (51). Primer
sequences used for seryl tRNA synthetase were 50-GAGG
AATTTTACGTGTTCATCAA-30 (forward) and 50-GAT
TACTTGTAGGAAAGAATCCTTC-30 (reverse). RT–
PCR products were analyzed through electrophoresis
on 1% agarose gel in TAE buffer at 10V/cm. For
immunodetection, parasites (10% parasitemia) from
ring, trophozoite and schizont stages were prepared by
lysis of infected RBC with 0.05% saponin. Released
parasite was centrifuged and washed thrice with PBS,
and suspended in 1  PBS. The isolated parasite was
lysed in PBS containing protease inhibitor cocktail
(Sigma) by mild sonication (5s pulse, bath type sonicator)
at 4 C and the whole lysate was then resolved in 12%
SDS–PAGE and electroblotted onto the nitrocellulose
membrane. After incubating the blots with rabbit poly-
clonal anti-PfAlba3 and anti-PfSir2A antibodies (1:5000
dilutions) or rabbit pre immune sera at room temperature
for 2h with constant shaking, it was washed ﬁve times
with PBS containing 0.05% (v/v) Tween-20. Membrane
was further incubated with HRP conjugated anti-rabbit/
anti-mouse antibody for 1h with constant shaking, blot
was washed and developed using a chemiluminescence de-
tection system. Anti-tubulin antibody was used as control.
Immunoprecipitation
PfAlba3 and PfSir2A from the parasite lysate were
immunoprecipitated by anti-PfAlba3 and anti-PfSir2A
antibody, respectively. In brief, parasite ( 10% parasit-
emia) was released by 0.05% saponin treatment, washed
with PBS and subsequently lysed in ice chilled RIPA
buffer (0.1% SDS, 0.5% Triton X-100, 0.5% sodium
deoxycholate, 1mM PMSF and protease inhibitor
cocktail) by incubation on ice for 45min. The lysate was
centrifuged at 14500g for 10min and the supernatant was
pre-cleared by the addition of Protein A sepharose beads.
The clear supernatant was incubated with primary anti-
body (rabbit anti-PfAlba3/mouse anti-PfSir2A antibodies)
for 6h at 4 C with simultaneous mixing on a rotating
wheel and centrifuged at 14500g for 20min. The super-
natant was further incubated for 12–14h with Protein A
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tion at 13000g for 5min at 4 C. Beads were then washed
with ice chilled RIPA buffer followed by a PBS wash.
Immunoprecipitated protein was obtained by treating
the beads with SDS Lamelli buffer and samples were
electrophoresed on a 15% SDS–PAGE.
Immunoﬂourescence studies
For immunodetection, parasite pellets containing ring,
trophozoite and schizont stages were washed with 1 
PBS and then boiled with 1  sodium dodecylsulfate
(SDS) gel loading buffer and loaded on 10% SDS–poly-
acrylamide gel. Western blot analysis was done using
afﬁnity puriﬁed anti-PfSir2A and anti-PfAlba3 antibodies
(1:5000) using the standard protocol. For localization
studies, synchronized parasites were cultured according
to standard procedures. Immunoﬂuorescence (IF)
analysis was performed in different asexual stages of the
parasite. Synchronized cultures of P. falciparum were
washed in phosphate-buffered saline (PBS), and ﬁxed in
4% paraformaldehyde and 0.0075% glutaraldehyde in
PBS for 20min. Cells were subsequently washed with
PBS and permeabilized with 0.1% Triton X-100 in PBS
for 10min. Slides were then blocked with 3% bovine
serum albumin (BSA) inPBSfor 1h at room temperature
and rinsed withPBS. Parasites were then incubated with
the primary antibodies (rabbit anti-PfAlba3 or mouse
anti-PfSir2A antibodies) diluted in 3% BSA overnight at
4 C. After that cells were washed three times (10min for
each wash) with PBS and incubated with secondary
antibody (Alexa Fluor 633 and Alexa Fluor 488 tagged
goat anti-rabbit IgG or goat anti-mouse IgG, Invitrogen)
diluted (1:500) in blocking solution for 1h at room tem-
perature. After ﬁnal washes, slides were mounted in
prolong gold antifade reagent (Invitrogen) with
4-6-diamidino-2-phenylindole (DAPI). Confocal images
were obtained with a Laser Confocal Microscope,
Olympus FluoView
TM FV1000 at 100  magniﬁcation
with oil immersion objective.
Nuclear and cytoplasmic extract preparation
Nuclear and cytoplasmic fractions were prepared essen-
tially as described earlier (52). In brief, Parasites from
mixed stage culture were isolated from infected red
blood cells by saponin lysis and washed twice in PBS, re-
suspend in ice-chilled lysis buffer (20 mM HEPES, pH 7.8,
10mM KCl, 1mM EDTA, 1mM DTT, 1mM PMSF,
0.65% NP-40) and incubated for 10min on ice. Nuclei
were pelleted by centrifugation (2500g) for 5min,
followed by separation of the supernatant (containing
cytoplasmic proteins) and stored at  80 C. The pellet
washed thrice in lysis buffer and suspended in extraction
buffer (20mM HEPES, pH 7.8, 800mM KCl, 1mM
EDTA, 1mM DTT, 1mM PMSF, 3mM pepstatin A
and 10mM leupeptin). The extract was subjected to
vigorous shaking at 4 C for 30min and cleared by centri-
fugation at 13000g for 30min. The supernatant (contain-
ing nuclear proteins) was diluted with one volume of
dilution buffer (20mM HEPES, pH 7.8, 1mM EDTA,
1mM DTT, 30% glycerol) and stored at  80 C.
Deacetylation assays
Deacetylation assays were performed using synthetic
peptide substrate following standard protocol in
presence of 2.5–10mg of recombinant PfSir2A. Reaction
mixtures were incubated at 37 C for 6h. All assays were
performed in triplicate. PfSir2A deacetylase activity was
monitored in 50ml of buffer containing 50mM Tris–HCl,
pH 8.0, 4mM MgCl2, 0.2mM dithiothreitol (DTT),
variable concentrations of nicotinamide adenine dinucleo-
tide (NAD
+, 0–500mM), 2.5–10mg of the puriﬁed recom-
binant PfSir2A and 10mg of the N-terminal peptide of
PfAlba3 (at lysine 22 and 23 at KKP sequence).
Reaction was initiated by the addition of enzyme and
incubated for 4–6h at 37 C. To check the effect of
NAD
+ on the PfSir2A-mediated lysine deacetylase
activity, assays were performed with or without NAD
+.
After the incubation, the products were precipitated at
 20 C overnight by adding 50ml of distilled water and
25ml of 100% trichloroacetic acid (TCA) solution. For
HPLC, the precipitates were reconstituted in 5%
CH3CN and 0.1% triﬂuoroacetic acid (TFA) and run
through a gradient concentration of 0.05% TFA to
0.043% TFA plus 80% CH3CN on Waters 1525 Binary
HPLC pump system with Deltapak C4 column (300A ˚ ,
3.9 300mm, Waters, USA) and analyzed by Empower
2 software (version 6.10.01.00). The chromatograms were
collected by dual–wavelength diode array with chromato-
grams analyzed at wavelength of 210/215nm. Reactions
were quantiﬁed by integrating area of peaks correspond-
ing to deacetylated peptides (identities of peptides con-
ﬁrmed by mass spectrometry). MALDI-mass analysis of
deacetylation reaction products were performed using
Kratos Kampact MALDI III machine (Shimadzu,
Duisburg, Germany).
Immunoﬂuorescence combined with ﬂuorescence in situ
hybridization
IF combined with ﬂuorescence in situ hybridization (IF–
FISH) was performed as described previously (31,41) with
a slight modiﬁcation. Brieﬂy, parasites were air dried on
glass slides for 30min at room temperature followed by ﬁx-
ation in 4% paraformaldehyde/PBS for 10min. The ﬁxed
parasites were permeabilized with 0.1% Triton X-100 and
then incubated with the primary (anti-PfAlba3) and sec-
ondary (Alexa ﬂour 488 conjugated) antibodies, followed
by another time ﬁxation using 4% paraformaldehyde/PBS
for 10min to preserve antibody complexes. To visualize
telomeric cluster, Rep20 probe was used. Hybridization
was performed overnight with 0.5–1ng/ml of probe in
50% formamide, 10% dextran sulfate (Quantum), 2 
SSPE and 250mg/ml herring sperm DNA.
ChIP assay
The chromatin immunoprecipitation assay was performed
as described earlier (31) with minor modiﬁcations. In
brief, parasites were isolated from infected erythrocytes
by saponin lysis and incubated with formaldehyde in a
ﬁnal concentration of 1% for 10min at 37 C. Cells were
collected after three washes with PBS and parasites were
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(25mM Tris–HCl, pH 8.0, 300mM NaCl, 1mM EDTA,
0.25% NP-40 and protease inhibitor cocktail) and kept on
ice for 30–60min for lysis. Parasites were subsequently
lysed by homogenizer and the nuclei were recovered by
centrifugation. This is followed by sonication at 40%
maximum amplitude (10s on, 60s off) for 12 pulses to
obtain DNA fragments in the range of 200–1000bp. The
samples were centrifuged for 10min at 15000g at 4 C.
For input DNA samples, an aliquot of lysate used in the
immunoprecipitation was processed along with the rest of
the samples.
Prior to immunoprecipitation, chromatin was diluted
10-fold in ChIP dilution buffer [0.01% SDS, 1.1%
Triton X-100, 1.2mM EDTA, 16.7mM Tris–HCl (pH
8.0) and 167mM NaCl] and pre-cleared using rabbit
IgG bound to protein A Sepharose for 2h at 4 C.
Pre-cleared chromatin was used for immunoprecipitation
reactions with a polyclonal antibody against PfAlba3 and
PfSir2A protein and non-immune serum was used as
control. The reactions were incubated on a rotor overnight
at 4 C. Chromatin complexes were precipitated with 80ml
of salmon sperm DNA–protein agarose slurry for 2h at
4 C, washed once in low salt immune complex wash
buffer, once in high salt immune complex wash buffer,
once in LiCl immune complex wash buffer and ﬁnally
two times in 10mM Tris–HCl, pH 8.0, 1mM EDTA.
Precipitated complexes were removed from the beads by
incubating for 30min in 250ml of 1% SDS with 100mM
NaHCO3. The protein–DNA cross-links were reversed by
heating samples at 65 C overnight in 250ml TE with
400mg Pronase (Roche). DNA was puriﬁed by phenol
chloroform extraction. DNA from input and ChIP
samples were resuspended in 100 and 20ml TE, respective-
ly. For PCR ampliﬁcation, 0.5ml of input DNA and 2mlo f
the ChIP sample were used as template. Primers were used
for the telomeric, TARE1, TARE2, TARE2-3, (11)
TARE6 (53) and promoter region of LSA (Liver stage
antigen), CSP (circumsporozoite protein) and GBP 130
(31) as previously published. The primers for 50-UTR
region of var genes (ups A, ups B, ups C and ups E)
were used as described previously (31,54). The PCR
products were analyzed on 1% agarose gel. All buffers
used in assay contained protease inhibitor cocktail.
ChIP ReChIP assay
ChIP ReChIP experiment was performed to further
conﬁrm the association between PfSir2A and PfAlba3 as
well as the status of PfAlba3. In brief, PfAlba3 or PfSir2A
antibodies were used for the ﬁrst round of immunopre-
cipitation and the order was reversed for the second
round of immunoprecipitation. While, to check the acetyl-
ation status of promoter bound PfAlba3, anti-acetyl lysine
antibody used for ﬁrst round and anti-PfAlba3 antibody
was used for second round.
In order to analyze the mutual association between
PfAlba3 and PfSir2A, we divided soluble chromatin frac-
tions (which were derived from cross-linked parasites) into
two aliquots. We immunoprecipitated the ﬁrst chromatin
aliquot with antibody to PfAlba3, washed it, released
the bound immune–DNA complexes using 25mM
dithiothreitol solution for 30min at 37 C and resuspended
them in one volume of immunoprecipitation dilution
buffer for ReChIP assay with antibody to PfSir2A. In
reciprocal way, we treated the second chromatin ali-
quot identically except that immune precipitated it with
PfSir2A antibody before ReChIP with antibody to
PfAlba3. To test antibody speciﬁcity, we used either a
no antibody control or an unrelated antibody.
RESULTS
Identiﬁcation and molecular modeling of putative
DNA–RNA-binding protein
Plasmodium falciparum genome analysis reveals that
it encodes a putative DNA–RNA-binding protein, shows
sequence homology and structural similarity with
Alba family proteins (Figure 1A and Supplementary
Figure S1). Sequence alignment of PfAlba3 with other
known Alba sequences (with known 3D structure)
(19,27,55–57) revealed the presence of conserved residues
involved in DNA binding and dimer interface (Figure 1A).
Multiple sequence alignments indicated the wide presence
of Alba including Plasmodium, Leishmania, Trypanosoma,
Archaea and Arabidopsis (Supplementary Figure S1). Like
Archeal Alba, PfAlba3 also possesses conserved sequence
motif K(X)KP in the loop between helix1 and strand 1,
which comprises critical lysine involved in DNA binding
(Figure 1A and B) (20). In order to visualize structural
details of PfAlba3, we build the 3D model of PfAlba3
using an Alba protein from Archaeoglobus fulgidus (PDB
code: 1NFH) as reference structure (19). PfAlba3
monomer model structure shows reasonably good struc-
tural similarities with the known 3D structures of Alba
family (Supplementary Table S1). Alba family protein is
mainly dimeric in nature. Therefore, we modeled dimeric
structure of PfAlba3 to understand the structural com-
plexity and DNA-binding mode. Monomer models of
PfAlba3 were further used in protein–protein docking to
generate the probable dimerization model. Even though
predicting the dimerization mode through protein–
protein docking is a difﬁcult task, we could generate a
decent dimer model of PfAlba3 (Figure 1B and C). This
model shows strong structural similarity (overall root
mean square deviation of 0.9A ) with the 1NFH dimer
generated using X-ray crystallography (Supplementary
Table S1). Modeled structure of PfAlba3 belongs to mix
ab structure with four b strands (b1–b4) and two a helices
(a1 a2) (Figure 1B) as observed in other Alba family
proteins (19,20,27,55). Like other Alba proteins, PfAlba3
also has extended b hairpin arm between strands 3 and 4
(Figure 1B and C), which is suggested to interact with
minor groove of DNA (14). Dimer structure of PfAlba3
showed an asymmetric unit and allied by 2-fold symmetry.
The two b-hairpin of both monomers are separated from
each other by  54A ˚ (Figure 1C) and can accommodate
 15bp of B-form DNA. Helix a2 and strands b3–b4o f
both monomers is engaged in monomer association and
concomitant dimer formation (Figure 1C). Docking
studies provide an apparent image of PfAlba3–DNA
1178 Nucleic Acids Research, 2012,Vol.40, No. 3interaction and probable mode of DNA binding. It
suggests that PfAlba3 dimer binds with DNA in side by
side fashion and covers an area greater than one complete
turn of DNA. Loop L1 of both monomers is located in the
central part of the dimer, well placed to accommodate
DNA duplex. Loops L1, L3 and L5 play an important
role in DNA binding, whereas surface exposed lysines
present in KKP motif in the loop L1 (K22 and K23) are
found in very close proximity with the DNA double helix
(Figure 1D). Lysine (K) 56 and lysine (K) 67 of helix a2
are also located beneath the docked DNA, hence may be
involved in DNA binding. Apart from this, proline (P24)
from both chains and asparagine (N) 53, arginine (R) 88
and lysine (K) 92 are also found to be engaged in
PfAlba3–DNA interaction (Figure 1D).
Puriﬁcation and characterization of PfAlba3
PfAlba3 was overexpressed as soluble His-tag fusion
protein of expected size  13.0kDa and readily puriﬁed
to homogeneity by the combination of Ni-NTA afﬁnity
and HPLC gel ﬁltration chromatography (Figure 2A).
Speciﬁcity and homogeneity of PfAlba3 were further
conﬁrmed by western blotting using anti-His and anti-
PfAlba3 antibodies (Supplementary Figure S2A).
Secondary structure analysis of PfAlba3 by circular di-
chroism (CD) spectropolarimetry suggests that the a and
b content of the recombinant PfAlba3 are  26% and
 32%, respectively, and remaining part is assumed to
be randomly coiled and b turn structures. These results
are in close agreement with the predicted secondary
structure as calculated from HHpred and 3D model
(PfAlba3) predictions for helix contents (Supplementary
Table S2).
DNA-binding property of PfAlba3: modiﬁcation of lysines
interferes with DNA binding
The DNA-binding property of PfAlba3 was investigated
by following agarose gel retardation assay. The mobility
of super coiled DNA (using fX174 DNA) incubated with
PfAlba3 was shifted sharply at PfAlba3–DNA mass ratio
Figure 1. Molecular modeling and docking studies of PfAlba3. (A) PfAlba3 sequence is aligned with other known Alba fold containing proteins
whose 3D structures are known. DNA-binding residues (colored in pale green) and dimer interface residues (colored in light orange) are mapped
onto the alignment. Residues that involved in both DNA binding and dimer interface are marked in blue. Secondary structure of PfAlba3 derived
from the model displayed onto the alignment. Surface exposed lysines involved in DNA binding are marked by ‘*’, whereas those not involved in
DNA binding represented by ‘+’. The level of sequence homology is represented by using the bar chart. Key to the identities of the Alba sequences
aligned with PfAlba3 is represented as color-coded matrix (See the Supplementary Figure S1B). (B–D) Dimerization and DNA-binding studies of
PfAlba3. (B) Cartoon representation of 3D structures of chains A and B of PfAlba3 as derived from template structure 1NFH. (C) Cartoon
representation of the dimerization model of PfAlba3 chains A and B. (D) Plausible mode of DNA-PfAlba3 (dimer) interaction. Surface exposed
lysines (involved in DNA binding) from chains A and B are marked in red and blue, respectively, while other residues involve in DNA binding (from
chains A and B) are marked (N53, K56, K67, R88 and K92) as indicated in ﬁgure.
Nucleic Acids Research,2012, Vol.40, No. 3 1179of 0.8. The shifting was gradually increased with the
increase of PfAlba3–DNA mass ratio, showing maximum
shift at PfAlba3–DNA mass ratio of 16 (Figure 2B).
PfAlba3 has sequence homology with Alba domain
and docking studies suggest the role of surface exposed
lysine residues in protein–DNA interaction (Figure 1).
Therefore, to verify the role of lysine in DNA binding,
we modiﬁed lysines of PfAlba3 by acetylation and
also by trinitrobenzene sulfonate (TNBS, a lysine
modiﬁer). Acetylation was conﬁrmed by western blotting
using anti-acetyl lysine antibody, which selectively
recognized acetylated PfAlba3 but not native PfAlba3
(non-acetylated) (Supplementary Figure S2B). We have
acetylated PfAlba3 in a controlled fashion to prepare
mild and high acetylated forms to follow DNA binding.
Acetylation of PfAlba3 lowers its DNA-binding afﬁnity in
comparison to the native (non-acetylated) PfAlba3 as
indicated by the reduced shifting at mild acetylation at
varying concentrations of the protein (Figure 2B).
However, the highly acetylated PfAlba3 lost its
DNA-binding activity completely (Supplementary Figure
S2C and D). A similar result was observed with
TNBS-modiﬁed PfAlba3, where no shifting was detected
(Supplementary Figure S2C). In summary, our data of
Figure 2. Characterization of DNA-binding properties of PfAlba3. (A) Recombinant PfAlba3 was puriﬁed by Ni-NTA afﬁnity chromatography and
subsequently by HPLC. Lane M; Protein molecular weight marker, lane 1; Ni-NTA puriﬁed fraction and lane 2; HPLC puriﬁed protein. (B)
DNA-binding property of PfAlba3 was characterized by agarose gel retardation assay. Samples were run pair wise (acetylated and non-acetylated
protein at the same concentration) to evaluate the effect of lysine modiﬁcation (acetylation) on DNA-binding afﬁnity of PfAlba3. Lane P; fX174
dsDNA alone, while subsequent lanes contain fX174 dsDNA plus increasing concentrations of native or mild acetylated PfAlba3, respectively. Ac;
mild acetylated PfAlba3 and N; native PfAlba3. (C) EMSA and supershift assay. Lane 1; probe alone; lanes 2–7; probe incubated with increasing
concentrations of PfAlba3 (20, 40, 80 120, 240 and 300nM) and lane 8, probe plus PfAlba3 (300nM) and anti-PfAlba3 antibody. (D) Competition
assay. Lane 1; probe alone, lane 2; probe plus PfAlba3 (300nM), lanes 3–10; probe plus PfAlba3 (300nM) along with an excess cold competitor (1, 5,
10, 20, 40, 60, 80 and 100 fold) DNA. (E) Determination of dissociation constant using 20-bp oligonucleotide. Lane 1; probe, lanes 2–13; probe along
with 10, 20, 40, 60, 80, 120, 180, 240, 320, 400 and 480nM of PfAlba3. (F) PfAlba3 concentrations were plotted against corresponding percent-bound
fractions (inset). Dissociation constant (Kdapp) was calculated from the plot using Scatchard equation. Data for each signal (free and bound DNA)
was performed in triplicate and reported error bar represent the standard deviation. (G and H) PfAlba3 interacts with minor groove of dsDNA.
Complementary oligonucleotide was annealed, radiolabeled with g P
32 ATP and subsequently incubated with increasing concentration of (G) methyl
green (major groove-binding dye) lanes 3–7; 0.01, 0.1, 5, 50 and 500mM and (H) Actinomycin D (minor groove-binding dye) Lanes 3–7; 0.01, 0.1, 5,
50 and 500mM. The reactions were further incubated with 500nM PfAlba3 and analyzed on 7% native PAGE. Lanes 1 and 2 (both in Figure G and
H) represented only labeled DNA (control) and labeled DNA incubated with PfAlba3 (500nM), respectively.
1180 Nucleic Acids Research, 2012,Vol.40, No. 3protein modiﬁcation reveal that non-acetylated PfAlba3
binds well with DNA; mild acetylation lowers its
binding whereas no binding was observed at high acetyl-
ation. Modiﬁcation of PfAlba3 did not signiﬁcantly alter
the structural integrity of PfAlba3 as evident from CD and
ﬂuoremetric analysis (Supplementary Figure S3 and
Supplementary Table S2).
PfAlba3 binds DNA sequence non-speciﬁcally
DNA-binding nature of PfAlba3 was also followed by
EMSA using 50-end-labeled ds oligos. The smallest
binding-site length of PfAlba3 was determined by using
ds oligonucleotide probes of 20 and 30bp. When the
DNA (using 30-bp ds oligos) incubated with PfAlba3
and resolved in native gel showed two distinct bands of
proteins: DNA complexes (complex I and II) (Figure 2C).
These bands became intense with the increasing concen-
tration of PfAlba3 (Figure 2C, lanes 2–7). When
anti-PfAlba3 antibody was added in the reaction, it
super shifted both proteins: DNA complexes (Figure 2C,
lane 8). Competition experiments were also carried out in
order to reconﬁrm the binding afﬁnity of PfAlba3 using
50-end labeled and non-radiolabeled (cold DNA) ds oligos
(30bp) (Figure 2D). At 20-fold excess of cold competitor
oligos the complex I (upper shifted band) is almost
vanished but not complex II (Figure 2D, lane 6).
However, 60-fold excess or onwards of cold competitor
probe completely prevented the formation of both the
protein: DNA complexes (Figure 2D, lanes 8–10).
On the other hand, when 20bp ds oligos were used only
one shift equivalent to protein: DNA complex was
observed (Figure 2E). These analyses suggest the
possible binding site length is  15bp of substrate per
dimer of PfAlba3. The afﬁnity of the PfAlba3 for DNA
was determined by calculation of Kdapp (apparent dissoci-
ation constant) of the single complex obtained with the
20-bp probe applying linear regression by using
Scatchard equation. The nucleotide binding of PfAlba3
revealed Kdapp value in nano molar range ( 87nM)
(Figure 2F).
We further check whether PfAlba3 has any major or
minor groove speciﬁcity for binding. Groove speciﬁc
dyes are used that speciﬁcally interact with either the
major or minor groove of DNA and compete with the
protein binding. Pre-incubation of DNA with increasing
concentrations of methyl green (major groove binder) did
not affect the binding activity of PfAlba3 (Figure 2G,
lanes 3–7), even at a very higher concentration (500mM)
(Figure 2G, lane 7). In contrast, actinomycin D (minor
groove binder) initiated partial inhibition of DNA
binding at 5mM (Figure 2H, lane 5) with considerable in-
hibition at 50mM (Figure 2H, lane 6) and complete inhib-
ition at 500mM (Figure 2H, lane 7), indicating that
PfAlba3 binds to minor groove of DNA. However, the
concentration of actinomycin D required for inhibition
was very high.
PfAlba3 prevents transcription after DNA binding
Existing studies of Alba proteins suggest that this family
proteins are not involved in DNA folding and chromatin
packaging (14,26). Since, acetylation has an impact on
DNA-binding activity; it is assumed that Alba may have
some role in the regulation of gene expression and tran-
scriptional modulation. In order to verify this hypothesis,
we performed in vitro transcription assay in the presence
of native (non-acetylated) and mild acetylated PfAlba3.
Data indicate that PfAlba3 prevents transcription concen-
tration dependently (Supplementary Figure S4A).
PfAlba3 at a lower concentration (100ng) partially pre-
vented transcription of tRNA
lysine, resulting in additional
bands corresponding to aborted short transcripts.
However, at higher concentrations (0.5–4mg), PfAlba3
showed gradual inhibition of transcription resulting in
the formation of numerous shorter transcripts
(Supplementary Figure S4A). In contrast, complete inhib-
ition of transcription was observed at 6–10mg of PfAlba3,
generating only very small short transcripts ( 6–10nt)
instead of full-length transcripts. Transcription under
control conditions (without PfAlba3 or heat inactivated
PfAlba3), and in the presence of only buffer produced
full-length transcript (tRNA
lysine) without any aborted
product. This suggests that transcription abortion was
not due to buffer or any hindrance to polymerase.
Interestingly, mild acetylated PfAlba3, even at a very
high concentration (10mg) was unable to inhibit transcrip-
tion (Supplementary Figure S4B). These ﬁndings indicate
that PfAlba3 by binding dsDNA blocks transcription and
acetylated PfAlba3 is unable to prevent transcription due
to reduced DNA-binding afﬁnity.
PfAlba3 expression and localization
Stage-speciﬁc expression of PfAlba3 was checked by RT–
PCR and western blotting using anti-PfAlba3 antibody.
Ampliﬁcation of a fragment of 324bp, equal to the size
of PfAlba3, was found in RT–PCR using RNA from ring,
trophozoite and schizont stages (Figure 3A). Seryl tRNA
synthetase was used as control, which is expressed uni-
formly throughout all the stages. The quantitative
analysis of the expression (RT–PCR data) indicated
almost equal level of expression of PfAlba3 throughout
all the asexual stages (Figure 3A, side panel). This
ﬁnding was further supported by western blot analysis of
parasite lysate prepared from different stages. Western
blot analysis using anti-PfAlba3 antibody showed the
presence of a single band of  12kDa, matched with the
calculated molecular weight of parasite expressed PfAlba3
(Figure 3B), uniformly at all the blood stages of malaria
parasite (Figure 3B, side panel). We further investigated
the subcellular localization of PfAlba3 during the asexual
developmental cycle by confocal microscopy (Figure 3C)
and western blotting using the cytoplasmic and nuclear
fraction isolated from mixed stages culture (Figure 3D).
IF analysis showed that PfAlba3 (alexa ﬂuor 633, red)
signal merged well with the DAPI signal indicating its
nuclear localization and reconﬁrmed its constitutive
expression (Figure 3C). PfAlba3 appeared as making
distinct subnuclear spot and concentrated mainly toward
the periphery of the nucleus during ring stages, whereas
during trophozoite and schizont stages PfAlba3 seems
distributed throughout the nucleus with more visible
Nucleic Acids Research,2012, Vol.40, No. 3 1181punctate staining pattern (Figure 3C). Immunoblot
analysis of parasite nuclear extracts with anti-PfAlba3
antibody detected a band ( 12kDa), suggesting the
major nuclear compartmentalization (Figure 3D).
However, a very weak signal was also detected in the cyto-
plasmic fraction in western blot (Figure 3D).The purity of
isolated subcellular fractions (cytoplasmic and nuclear)
was conﬁrmed by western blot analysis using anti-histone
H3 (nuclear) and anti-tubulin (cytoplasmic) antibody
(Figure 3D). Presence of PfAlba3 in parasite was further
ensured by immunoprecipitation from the whole parasite
lysate using anti-PfAlba3 antibody. Antibodies raised
against recombinant PfAlba3 speciﬁcally pulled out a
 12kDa protein that was speciﬁcally recognized by
rabbit anti-PfAlba3 antibody (data not shown). To
check the existence of acetylated form of PfAlba3 in
parasite, the whole PfAlba3 was ﬁrst immunoprecipitated
by anti-PfAlba3 antibody and then divided into two equal
parts for western blotting using anti-PfAlba3/anti-acetyl
lysine antibodies (Figure 3E). Results document the
presence of a detectable band in both the fractions
(Figure 3E, lanes 2 and 4) proving that PfAlba3 also
exists in an acetylated form in P. falciparum. However,
no signal was detected when rabbit pre-immune serum
was used for immunoprecipitation (Figure 3E, lanes 3
and 6). Recombinant PfAlba3 and acetylated PfAlba3
were used as positive control (Figure 3E, lanes 1 and 4).
Quantitative analysis of the immunoprecipitation experi-
ments indicates that PfAlba3 exists predominantely in an
acetylated form ( 80% of the total PfAlba3 population)
in P. falciparum (Figure 3E, side panel).
PfSir2A interacts with PfAlba3 and deacetylates
N-terminal peptide speciﬁc for DNA binding
To explore the function of PfAlba3, identiﬁcation of
critical proteins involved for acetylation–deacetylation in
Figure 3. Stage-speciﬁc expression and subcellular localization of PfAlba3. (A and B) Stage-speciﬁc expression of PfAlba3 transcript was conﬁrmed
from total RNA isolated from sorbitol synchronized P. falciparum culture at ring (R), trophozoit (T) and schizont (S) stages. RT
  control represents
reaction without reverse transcriptase. Side panel shows densitometric analysis of PfAlba3 expression at different stages of P. falciparum. Band
intensities were quantiﬁed by spot densitometry using AlphaImager 3400 imaging software (Alpha Innotech Corporation) and the intensity of
PfAlba3 transcript was normalized to that of seryl tRNA synthetase. (B) Western blot analysis of PfAlba3 expression in P. falciparum
intra-erythrocytic stages. The sorbitol synchronized parasite lysate was resolved in 15% SDS–PAGE and subjected to western blotting using
anti-PfAlba3 antibody. To conﬁrm the equal amount of protein in parasite lysate, blot was reprobed with anti-tubulin antibody. Side panel
shows densitometric analysis and intensity of PfAlba3 was normalized against tubulin. (C) Subcellular localization of PfAlba3 was conﬁrmed by
IF analysis of PfAlba3 (Red, Alexa ﬂour 633) throughout the parasite asexual blood stages (ring, early and late trophozoite, schizont stages). (D)
Nuclear localization of PfAlba3 was further conﬁrmed by western blotting using cytoplasmic and nuclear fraction from asynchronous parasite
culture. To cross check the possibilities of contamination of cytoplasm and nuclear fraction with each other, we also performed the experiment using
cytoplasmic (anti-tubulin antibody) and nuclear (anti-Histone H3) marker proteins. (E) PfAlba3 also exists in the acetylated form. To conﬁrm
acetylation status of PfAlba3 in parasite, immunoprecipitated batch of protein was equally divided in two fractions and subjected to western blotting
using rabbit anti-PfAlba3 antibody for ﬁrst and mouse anti-acetyl lysine antibody for second fraction. Rabbit pre-immune serum was used as a
control in all the experiments. Left panel showing lane 1; puriﬁed recombinant PfAlba3 (control), lane 2; immunoprecipitation with rabbit
anti-PfAlba3 antibody, lane 3; immunoprecipitation with rabbit pre-immune serum. Right panel represents, Lane 4; acetylated PfAlba3 (control),
lane 5; immunoprecipitation with rabbit anti-PfAlba3 antibody; lane 6; immunoprecipitation with rabbit pre-immune serum. Side panel shows the
densitometric analysis of acetylated and non-acetylated PfAlba3.
1182 Nucleic Acids Research, 2012,Vol.40, No. 3P. falciparum is essential. Previous studies reported that
Alba binding is regulated by Sir2 through deacetylation,
speciﬁcally at N-terminal lysine residue (14,17).
Interestingly, P. falciparum genome also encodes a
homolog of Sir2, a NAD
+-dependent deacetylase
(13).Therefore, we have cloned and overexpressed GST
and His fusion tagged PfSir2A to verify the interaction
of PfSir2A with PfAlba3 (as a non-histone substrate).
GST pull-down assays were conducted by using puriﬁed
GST-PfSir2A and His-tagged PfAlba3 (Figure 4A). The
data indicate that PfSir2A interacts well with PfAlba3 as
evident from the presence of PfAlba3 in pulled out
material (Figure 4A, lanes 3 and 5). Whereas, no inter-
action was found when PfMIF (P. falciparum macrophage
migration inhibitory factor, His-tag fusion protein, used
as control) was used (Figure 4A, lanes 2 and 4). However,
GST alone did not interact with PfAlba3 suggesting
its speciﬁcity toward PfSir2A not to GST (Figure 4A,
lane 1). These results were further supported by far
western analyses (Supplementary Figure S5B).
To further investigate the interaction between PfAlba3
and PfSir2A, we raised polyclonal antibodies against the
recombinant PfSir2A and performed His-tag pull-down
assay using His-tagged PfAlba3 as bait and incubated it
with parasite lysate to pull out an interacting partner using
Ni-NTA. Pulled down material was analyzed by western
blot using anti-PfSir2A antibody, which indicated the
presence of a band  30kDa (Figure 4B, lane 4), speciﬁc
to parasite encoded PfSir2A.To detect the speciﬁcity of
antibody, we immunoprecipitated PfSir2A from the
parasite lysate as well (Figure 4B, lane 1). Immunoblot
analysis of parasite extracts with anti-PfSir2A antibody
also detected a 30-kDa protein at the same position
(Figure 4B, lane 2). Whereas, no band was detected in
His fusion PfMIF pulled out material (Figure 4B, lane
3). Docking studies suggested the role of critical
N-terminal lysines (in KKP motif) in DNA binding,
which may be regulated by acetylation and deacetylation
similar to Archea (14,17). To test the signiﬁcance of
N-terminal lysine in DNA binding by PfAlba3, we used
23 residue synthetic peptide [residues 7–29] corresponding
to N-terminal of PfAlba3, acetylated at lysine (K) 22/
lysine (K) 23 and followed deacetylation using PfSir2A
(Figure 5). In the absence of NAD
+ and PfSir2A, these
peptides showed one prominent peak corresponding to the
non-acetylated or acetylated peptides (K22 or K23), re-
spectively (Figure 5A and F). When acetylated peptides
(K22/ K23) were incubated with only PfSir2A, no add-
itional peak was observed (Figure 5B and G). However,
when acetylated (K22/K23) peptides were incubated with
PfSir2A in the presence of NAD
+ additional peak was
observed, which became more prominent with increasing
concentrations of NAD
+ (Figure 5C–E and H–J). This
additional peak was collected and mass was analyzed,
which corresponds to deacetylated species of the peptide
(non-acetylated  2687Da) (data not shown). However,
deacetylation was selectively favored at K22, but not at
K23 as evident from comparative HPLC chromatograms
of deacetylation reaction with K22
Ac and K23
Ac peptides
(Figure 5E and J). About 60% of the K22
Ac peptide
(Figure 5E) was deacetylated, whereas <20% of K23
Ac
peptide was deacetylated under the same condition
(Figure 5J). Fractions of deacetylation reaction using
K22
Ac/K23
Ac peptides were collected and processed for
mass analysis to further conﬁrm the deacetylation
(Supplementary Figure S6A–C). Mass data show the
presence of mixed population containing two main
peaks corresponding to acetylated and deacetylated
forms (Supplementary Figure S6B–C).
Co-localization and ChIP studies
Since the recombinant PfSir2A can deacetylate synthetic
peptide speciﬁc to N-terminus of PfAlba3 as substrates,
Figure 4. PfAlba3 interacts with PfSir2A. (A) GST pull-down assay. Lane 1; GST alone, Lanes 2 and 4; 25 and 50ml of pulled out material of
PfSir2A (GST tag) incubated with PfMIF (His tagged), Lanes 3 and 5; 25 and 50ml pulled out material of PfSir2A (GST tagged) incubated with
PfAlba3 (His tag). (B) His tag pull-down assay and immunoprecipitaion. PfSir2A was pulled down from the whole parasite lysate (mixed stage) using
His tag PfAlba3 as well as immunoprecipitated using anti-PfSir2A antibody. The samples were then subjected to SDS–PAGE analysis, followed by
western blotting using anti-PfSir2A antibody. Lane 1; Immunoprecipitated PfSir2A using anti-PfSir2A antibody, lane 2; whole parasite lysate, lane3 ;
pull down material using His tag PfMIF, lane 4; pull down material using His tag PfAlba3. Puriﬁed His tag PfMIF used as a control in all the
experiments.
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1184 Nucleic Acids Research, 2012,Vol.40, No. 3we checked whether PfSir2A and PfAlba3 are positioned
in the same genomic location or not. To test this, we per-
formed dual IF studies using rabbit anti-PfAlba3
and mouse anti-PfSir2A antibodies. The data indicated
the expression of both these proteins at different
intra-erythrocytic stages; however, low level of expression
of PfSir2A at ring stage was detected in comparison
to trophozoite and schizont stages (Figure 6A).
A similar result was also observed in western immunoblot
with parasite lysate using anti-PfSir2A antibodies
(Supplementary Figure S5A). IF studies show that
PfAlba3 (red) and PfSir2A (green) ﬂuorescence signals
merge at several places (Figure 6A) foremost at the per-
ipheral region of the nucleus. However, co-localization
was partial and not signiﬁcant during schizont stage as evi-
dent from the overlap and non-overlap scores (Figure 6A,
side panel). PfSir2A and PfAlba3 signals occupied mainly
toward the periphery of the nucleus and making discrete
foci. PfSir2A is not considered as a speciﬁc marker for
telomeric clusters and also reported to stain the nucleolus
as well (31). Hence, we carried out IF–FISH to analyze the
association of PfAlba3 at the telomeric region (Figure 6B).
Visualization of the telomeric clusters during the
blood-stage cycle of malaria parasite was performed by
IF–FISH using TARE6 sequence as a probe. The
co-localization of PfAlba3 with telomeric cluster at the
nuclear periphery was also observed suggesting the telo-
meric association of PfAlba3 (Figure 6B).
Previous studies showed a key role of P. falciparum Sir2
in heterochromatin-mediated silencing and comprehensive
repression and switching expression of var genes and telo-
meric maintenance (31,41). To get a preliminary idea of
the possible role of PfAlba3 in PfSir2A-mediated regula-
tion of gene expression, we moved for ChIP and ChIP
ReChIP assays using highly synchronized ring stage
parasite (Figure 7). ChIP analyses show that PfSir2A
binds to telomeric region, including telomere, telomeric
repeats and rep 20 (TARE 6) but not at promoter
regions of GBP130 (blood stage expressed), LSA and
CSP (not expressed during blood stage) (Figure 7A, left
Figure 6. Co-localization studies. (A) Plasmodium falciparum infected red blood cells were treated with DAPI (blue), mouse anti-PfSir2A antibody
(secondary antibody Alexa Fluor 488, green) and rabbit anti-PfAlba3 antibody (secondary antibody Alexa Fluor 633, red), respectively. Overlay
panels show the merged images in different combinations. Side panel shows the score values of co-localized and non-co-localized ﬂuorescence signals
at ring, trophozoite and schizont stages, (B) FISH analysis combined with IF labeling of PfAlba3 to visualize telomeric region of chromosomes.
Immunolocalization (IF) of PfAlba3 was performed at ring stage parasites using an Alexa 488-conjugated secondary antibody (green). FISH analysis
was performed simultaneously. The nuclei were stained with DAPI (blue) and hybridized with TARE6 (Red) probe to visualize the chromosome ends
on ring stage. The extent of co-localization in the selected image was measured (side panel) using the Pearson correlation coefﬁcient and expressed as
a percentage using Image Pro Plus software. For co-localization studies (IFA and IFA–FISH), approximately 100 nuclei were counted and repre-
sented as mean±SD. The images presented are a representation of one of the experiments.
Nucleic Acids Research,2012, Vol.40, No. 3 1185panel), as also reported earlier (11,31,39). Input DNA
(nuclear DNA prepared immediately after sonication)
was used as a control. Results of ChIP assay using anti-
PfAlba3 also followed a similar pattern (Figure 7A, right
panel), which again suggested the telomeric and
subtelomeric location of PfAlba3. The regulation of var
genes expression is controlled by distinct promoters (sym-
bolize as ups A–C and E) located in the subtelomeric
region (A, B and E) and center of the chromosomes
(ups C) (34,58). Role of PfSir2A is well established in
the regulation of var gene expression; therefore, we per-
formed ChIP assays against var gene promoter using
anti-PfSir2A and anti-PfAlba3 antibodies (Figure 7B) to
check whether PfAlba3 has any association with these
promoters. We found that anti-PfSir2A antibodies
immunoprecipitated ups B and ups E var gene promoter,
but not ups A and ups C (Figure 7B, left panel). However,
ChIP analysis using anti-PfAlba3 showed a slightly differ-
ent picture and immunoprecipitated ups A, B and E, but
how this can be attributed is not clear (Figure 7B,
right panel). To further make the picture clear, we per-
formed ChIP ReChIP assay using a combination of
anti-PfSir2A/anti-PfAlba3 as well as anti-acetyl lysine/
anti-PfAlba3 antibodies. The ChIP ReChIP studies
suggest that ups E and ups B promoters are enriched
with both PfAlba3 and PfSir2A but not ups C and A
promoters as evident from successive immunopre-
cipitation (Figure 7C, left panel) using anti-PfAlba3/
anti-PfSir2A antibodies. Interestingly, ChIP ReChIP
using anti-acetyl lysine/anti-PfAlba3 antibodies immuno-
precipitated ups A only suggesting that PfAlba3 is in an
acetylated form at ups A promoter but not at ups B and E
promoters (Figure 7C, right panel), hence not picked up in
ChIP Re ChIP.
DISCUSSION
In the present study, we have identiﬁed and characterized
an Alba family protein (PfAlba3) from P. falciparum.
We have presented evidence that PfAlba3 is expressed
in all the erythrocytic developmental stages of P. falcip-
arum. PfSir2A interacts with PfAlba3 and deacetylates
N-terminal peptide of PfAlba3 speciﬁc for DNA
binding. Our results also documented the association
between PfAlba3 and PfSir2A at telomeric, subtelomeric
regions and var gene promoter.
Alba protein originates from a group of ancient nucleic
acid-binding protein and predominantly present in
Archaea suggested the evolutionary divergence of this fam-
ily of proteins among other groups, including Plasmodium.
Figure 7. ChIP and ChIP ReChIP analysis (A) ChIP analysis performed from ring stage parasites using antibodies against PfSir2A (left panel) and
PfAlba3 (right panel). Immunoprecipitated DNA was analyzed by PCR ampliﬁcation speciﬁc to telomeric and subtelomeric sequences (TARE1,
TARE2, TARE2-3 and TARE6), GBP130, LSA and CSP 50-UTR region. Input DNA material was used as a positive control, whereas material
immunoprecipitated by the pre-immune sera or IgG used as control. PfAlba3 and PfSir2A are assembled at the telomeric and subtelomeric regions of
chromatin, as shown by ChIP analysis. (B) PfAlba3 is also associated to the 50-UTR of var genes. ChIP analysis of ring stage parasites was
performed using antibodies against PfSir2A (left panel) and PfAlba3 (right panel). (C) PfAlba3 and PfSir2A are assembled at same promoter
region and the association between PfSir2A and PfAlba3 causes its deacetylation, as shown by ChIP ReChIP analysis. Soluble chromatin was
prepared from isolated parasites and divided into two chromatin aliquots, which were immunoprecipitated with antibodies to either anti-PfSir2A/
PfAlba3 antibody or anti-acetyl lysine/PfAlba3 antibody, respectively. Controls for the ChIP ReChIP fractions include the input chromatin and
pre-immune serum. Input corresponds to DNA prepared from fragmented chromatin prior to immunoprecipitation. Each experiment was performed
in triplicate and the data presented were a representation of one out of three experiments showing similar result.
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other proteins belonging to Alba family. Structural
studies with Alba protein show that each dimer of Alba
has two extended b-hairpins ﬂanking a central body which
is suggested to interact with DNA (27). This extended anti
parallel b-hairpin structure plays a central role in DNA
interaction by several DNA-binding proteins (59–61).
Molecular modeling and docking studies of PfAlba3 also
revealed a similar kind of structure and mode of inter-
action with DNA. PfAlba3 binds well with DNA
without any sequence speciﬁcity and acetylation lowers
the binding afﬁnity of PfAlba3, a characteristic feature
of proteins belonging to Alba family. PfAlba3 contains
large numbers of basic amino acid (10 lysines and 6 argin-
ines), out of which few are surface exposed and accessible
to modiﬁcation. Previous studies explored the presence of
N-terminal lysines in KKP motif (in loop L1, well
conserved among Alba family proteins) and their critical
role in DNA binding (14,17, 20). Docking of dsDNA with
PfAlba3 suggested a similar mode of DNA binding and
critical role of N-terminal lysines (K22 and K23) as well as
other residues (K56, K67, K92, R88, N53, etc.) in
stabilizing the interaction. However, due to lack of
proper strategy of in vivo modiﬁcation of protein at
speciﬁc lysines, we did in vitro modiﬁcation of PfAlba3
to analyze the effect of modiﬁcation on DNA binding.
The reduction or loss of binding after chemical modiﬁca-
tion of lysine validated the essential role of lysine in DNA
binding. Reaction with acetic anhydride is expected to
acetylate all surface lysine (total 7) side chains and not
just the speciﬁc residues whose enzymatically catalyzed
acetylation–deacetylation is expected to control DNA-
binding afﬁnity in vivo. It is true that in vivo acetylation
is a highly speciﬁc process and acetylation under in vitro
condition produced heterogeneous population. Therefore,
mutagenesis studies along with identiﬁcation of corres-
ponding acetyltransferase are essential for proper identiﬁ-
cation of speciﬁc lysine whose acetylation controls
PfAlba3 interaction with DNA.
PfAlba3 is uniformly expressed at all the intra-
erythrocytic stages of P. falciparum. This suggests that
PfAlba3 may play an essential role in all developmental
stages of the intra-erythrocytic life cycle of P. falciparum.
PfAlba3 also exists in the acetylated form in P. falciparum
indicating that the interaction and afﬁnity of PfAlba3
with DNA are possibly regulated by its acetylation/
deacetylation mode like other Alba family proteins
(14,17). Since we have quantiﬁed acetylated PfAlba3
using parasite from mixed stages, future studies are neces-
sary to see whether the acetylation status throughout all
the individual asexual stages remains constant or not.
PfAlba3 signiﬁcantly inhibited transcription under
in vitro condition. However, acetylated PfAlba3 did not
inhibit transcription even at a very high concentration.
This ﬁnding suggests that PfAlba3 binds DNA with low
afﬁnity under acetylated status as compared with
non-acetylated PfAlba3 and therefore, unable to inhibit
transcription. Sequence non-speciﬁc DNA binding and
its control by acetylation are common ways for the regu-
lation of gene expression (62). These ﬁndings suggest that
PfAlba3 might have some role in gene expression.
Recently, Mair and coworkers (63) have identiﬁed Alba
family proteins in maternal mRNP complex and suggested
the involvement of these proteins in zygote development
as well as post-transcriptional regulation of gene expres-
sion in Plasmodium. PfSir2A (NAD
+-dependent
deacetylase) interacts well with PfAlba3 as evident from
protein–protein interaction studies and deacetylates syn-
thetic N-terminal peptides (acetylated speciﬁcally at lysine
K22
Ac/K23
Ac) preferably at lysine 22. These studies along
with earlier reports suggest the importance of N-terminal
lysine residues in K(X) KP motif in DNA binding and
acetylation /deacetylation regulation. However, in our
studies, we have analyzed the role of N-terminal lysines,
but we cannot exclude the possibilities of involvement of
other lysines in DNA binding.
Data accumulated in recent years suggested an active
role of PfSir2A in controlling var genes expression (64).
PfSir2A is associated with the telomeric rep20 sequences
and therefore, spreads gene repression to  50-kb internal
regions of chromosome comprising var genes (11,31,41).
PfSir2A has been reported to be involved in regulating
subtelomeric var genes (ups A and ups E) whereas central-
ly located var genes (ups C) are not under direct control of
PfSir2A as also observed from PfSir2A knockout studies
(31,32,41). Confocal microscopic and FISH studies docu-
mented that both PfAlba3 and PfSir2A are localized in the
nucleus and occupies mainly at the telomeric and
subtelomeric region. These data suggest a possible
in vivo association and functional regulation of the
PfAlba3 by PfSir2A through its deacetylation. Since,
PfAlba3 lacks any organelle speciﬁc signal sequence but
its existence in acetylated/deacetylated forms advocates
the possibilities of its subcellular localization regulated
by acetylation and deacetylation. PfAlba3 and PfSir2A
co-localization is not signiﬁcant during schizontic stages
and during other stages it may be inevitably overlapped
due to peripheral localization of the nucleus. Recent
studies by Mani et al. (25) suggested that Alba proteins
from Trypanosoma brucei are cytoplasmic and involved in
translation regulation. However, in our microscopic
studies, we observed that during asexual blood stages
PfAlba3 is mainly nuclear in localization. But, in the
western blot analysis, we also observed a faint band in
the cytoplasmic fraction. This faint band is deﬁnitely not
due to any contamination of nuclear fraction as con-
ﬁrmed by western blotting using nuclear and cytoplasm
speciﬁc antibodies. These studies postulated the nucleo-
cytoplasmic localization of PfAlba3, regulated probably
by acetylation/deacetylation mechanism. Therefore, it
may be possible that PfAlba3 may be dual in localization
based on need and cellular stage, biological stress as well
as regulation mediated by corresponding acetylase and
deacetylase counterpart.
ChIP data revealed the presence of PfSir2A at the telo-
meric, subtelomeric region and at var gene promoters. The
data also documented the presence of PfSir2A during ring
stage at ups B and E var promoter region but not at ups C
and E. The presence of PfSir2A at promoter regions attri-
butes silencing of downstream genes and its absence
suggests active transcription. However, the transcription
proﬁles of var genes vary within individuals or in a
Nucleic Acids Research,2012, Vol.40, No. 3 1187population. Differential expression of var genes are
associated with several factors, including disease severity
(65), exposure to biological stress (66) and disease pheno-
type (54,65,67). ChIP assay using PfAlba3 antibody shows
its presence at telomere, TARE repeat sequence but not at
GBP, LSA and CSP promoter. Interestingly, PfAlba3
immunoprecipitated ups A, B and E promoter but not
ups C suggesting the absence of PfAlba3 at centrally
located var gene (ups C) as well as far away gene pro-
moters ( 100kb). These results suggested the correlation
between PfSir2A and PfAlba3. Since, PfSir2A binding
spreads out to the subtelomeric repeat Rep20 and is not
associated with the genes located too far (>100kb) from
telomere end. To elucidate the association between
PfSir2A and PfAlba3, we further performed ChIP
ReChIP assay. Results validate the association of
PfAlba3 and PfSir2A at ups B and E promoters but not
at ups A and ups C promoters. However, PfAlba3 is
present at these promoters (ups A, B and E) but differs
in acetylation status. At ups A it is in acetylated status but
not at ups B and E, where it is in deacetylated status and
this deacetylation is probably mediated by PfSir2A.
Indeed,vargenes silencing involves heterochromatin
formation mediated by PfSir2A and involves reversible
modiﬁcation in the histone tail. In our studies, we
found the presence of PfAlba3 at telomeric and
subtelomeric regions shared with PfSir2A and presence
of PfSir2A employed deacetylation of PfAlba3 as
evident from ChIP and ChIP ReChIP assays. However,
a marginal co-localization in IF studies was evident but
co-immunoprecipitation and chromatin immunopre-
cipitation experiments showed the physical association
between PfAlba3 and PfSir2A. Again, PfSir2A could
deacetylate peptides speciﬁc for N-terminal DNA-
binding region of PfAlba3. Therefore, it is highly
possible that PfAlba3 may be involved in telomere
position effect and epigenetic contribution to the regula-
tion of gene expression mediated by PfSir2A. Future
studies using antigenic homogeneous parasitic population
combined with knockout and microarray analysis should
be needed for better understanding of the precise role of
PfAlba3. In conclusion, our studies reveal that PfAlba3,
an Alba family protein serves as a non-histone substrate
for PfSir2A and may cooperate for var gene expression in
P. falciparum.
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